It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AZN’s FA Score shows that 2 FA rating(s) are green while.
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AZN’s TA Score shows that 4 TA indicator(s) are bullish.
AZN (@Pharmaceuticals: Major) experienced а +0.08% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.21%. For the same industry, the average monthly price growth was +1.66%, and the average quarterly price growth was +17.86%.
AZN is expected to report earnings on Feb 05, 2026.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
AZN | ||
|---|---|---|
OUTLOOK RATING 1..100 | 20 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 24 Undervalued | |
PROFIT vs RISK RATING 1..100 | 26 | |
SMR RATING 1..100 | 45 | |
PRICE GROWTH RATING 1..100 | 43 | |
P/E GROWTH RATING 1..100 | 44 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AZN | PPH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 47% | 1 day ago 86% |
| Stochastic ODDS (%) | 1 day ago 47% | 1 day ago 72% |
| Momentum ODDS (%) | 1 day ago 69% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 62% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 56% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 56% | 1 day ago 81% |
| Advances ODDS (%) | 4 days ago 55% | 4 days ago 80% |
| Declines ODDS (%) | 1 day ago 43% | 1 day ago 78% |
| BollingerBands ODDS (%) | 1 day ago 44% | 1 day ago 75% |
| Aroon ODDS (%) | 1 day ago 53% | 1 day ago 79% |
A.I.dvisor indicates that over the last year, AZN has been loosely correlated with GSK. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then GSK could also see price increases.
| Ticker / NAME | Correlation To AZN | 1D Price Change % | ||
|---|---|---|---|---|
| AZN | 100% | -0.35% | ||
| GSK - AZN | 65% Loosely correlated | -0.50% | ||
| NVS - AZN | 61% Loosely correlated | -2.32% | ||
| SNY - AZN | 54% Loosely correlated | -1.33% | ||
| ABBV - AZN | 52% Loosely correlated | -1.49% | ||
| BIIB - AZN | 50% Loosely correlated | +0.15% | ||
More | ||||
A.I.dvisor indicates that over the last year, PPH has been closely correlated with PFE. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if PPH jumps, then PFE could also see price increases.